Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AstraZeneca bets another $140 million on Moderna's 'messenger' drugs
Thursday, August 11, 2016AstraZeneca has invested another million in Moderna Therapeutics the US biotech unicorn which already has a cash pile of around billion and is developing drugs based on a molecule known as messenger RNA The British drugmaker said on Wednesday that...
FDA Accepts Marathon Pharmaceuticals’ New Drug Applications for Deflazacort
Thursday, August 11, 2016Marathon Pharmaceuticals LLC a biopharmaceutical company developing treatments for rare diseases today announced the New Drug Applications NDA for the investigational drug deflazacort have been accepted for filing and granted Priority Review by the U...
AstraZeneca drug selumetinib fails in lung cancer study
Wednesday, August 10, 2016AstraZenecas cancer drug pipeline suffered a setback on Tuesday when the experimental drug selumetinib failed to meet its goal in a latestage trial for lung cancer Hopes for the medicine had already been reduced after it failed in another study for...
Mylan second-quarter profit edges higher; EPS forecast unchanged
Wednesday, August 10, 2016Mylan NV on Tuesday reported slightly higher second quarter profit on increased demand for its generic medicines and specialty drugs such as the EpiPen injector for severe allergic reactions and expressed confidence in its longrange earnings forecast...
Jointown Pharmaceutical Group unit plans to set up JV
Wednesday, August 10, 2016Jointown Pharmaceutical Group Co Ltd Says it wholly owned unit to invest million yuan to set up JV in Jiangsu with Jiangsu Yuyue Medical Equipment and Supply Co Ltd Says the JV will undertake wisdom logistics cooperation project with registered cap...
Moberg Pharma Announces Approvals to Start Phase 3 Study for MOB-015 in U.S. and Canada
Wednesday, August 10, 2016Moberg Pharma AB today announced that the US Food and Drug Administration FDA has approved the Companys Investigational New Drug IND application and that a No Objection Letter has been received from Health Canada to begin its Phase trial for MOB in...
Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology
Tuesday, August 09, 2016Arbutus Biopharma Corporation an industryleading hepatitis B virus HBV therapeutic solutions company today announced the issuance of a new patent US patent that bolsters Arbutus intellectual property for its proprietary lipid nanoparticle LNP deliv...
Helsinn Group, MEI Pharma enter deal for Pracinostat development
Tuesday, August 09, 2016Helsinn Group and Mei Pharma enter strategic agreement for the development and commercialization of pracinostat for the treatment of acute myeloid leukemia and other hematologic diseases To receive million in nearterm cash payments plus up to mill...
Alkermes submits supplemental new drug application to FDA
Tuesday, August 09, 2016Alkermes submits supplemental new drug application to FDA for two month dosing option of Aristada for treatment of schizophrenia Notice of allowance issued for Aristada patent application extending expected protection into Expects patent to issue w...
Scintilla to acquire Scilex Pharmaceuticals
Tuesday, August 09, 2016Scintilla Pharmaceuticals Inc in consideration for deal Scilex equity holders to receive up to million in stock of Scintilla after next equity financing of Scintilla Has entered into a binding term sheet to acquire Scilex Pharmaceuticals Inc Acqui...
